WebApr 11, 2024 · INDICATION AND LIMITATION OF USE FOR LOKELMA ® (sodium zirconium cyclosilicate) 5 g and 10 g for oral suspension. LOKELMA is indicated for the treatment of hyperkalemia in adults. LOKELMA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action. IMPORTANT SAFETY … WebThe FDA approved oral sodium zirconium cyclosilicate (ZS-9), to be marketed as Lokelma, for the treatment of hyperkalemia. The drug seems to work better than sodium polystyrene sulfonate (Kayexalate), reducing serum potassium levels within an hour and restoring normal levels after about 2 hours in most patients.
Sodium Zirconium Cyclosilicate - Memorial Sloan Kettering Cancer …
WebIt works by binding to potassium in the gut. This medication does not work right away, and should not be used to treat life-threatening high levels of potassium. ... Labeler Name Product Type; 0310-2111: Sodium Zirconium Cyclosilicate: Powder, For Suspension: Astrazeneca Pharmaceuticals Lp: Bulk Ingredient: NDC Lookup NDC Advanced Lookup ... WebApr 11, 2024 · INDICATION AND LIMITATION OF USE FOR LOKELMA ® (sodium zirconium cyclosilicate) 5 g and 10 g for oral suspension. LOKELMA is indicated for the treatment of hyperkalemia in adults. LOKELMA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action. IMPORTANT SAFETY … project plan how to
Lokelma (Sodium Zirconium Cyclosilicate): Uses, …
Sodium zirconium cyclosilicate, sold under the brand name Lokelma, is a medication used to treat high blood potassium. Onset of effects occurs in one to six hours. It is taken by mouth. Common side effects include swelling and low blood potassium. Use is likely safe in pregnancy and breastfeeding. It works by binding potassium ions in the g… WebJan 4, 2024 · Lokelma works by binding (attaching) to potassium in your digestive tract (your stomach and intestines). This is Lokelma’s mechanism of action (the way the drug … WebFeb 15, 2024 · Because sodium zirconium cyclosilicate is not orally absorbed it is unlikely to reach the breastmilk or adversely affect the breastfed infant. No special precautions are required. Drug Levels. … project plan phases definition